{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:52:21Z","timestamp":1792450341026,"version":"4.5.0"},"reference-count":69,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2015,5,6]],"date-time":"2015-05-06T00:00:00Z","timestamp":1430870400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clinic Rev Allerg Immunol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1007\/s12016-015-8487-6","type":"journal-article","created":{"date-parts":[[2015,5,5]],"date-time":"2015-05-05T10:49:39Z","timestamp":1430822979000},"page":"353-365","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":56,"title":["Mast Cell Activation Syndrome"],"prefix":"10.1007","volume":"54","author":[{"given":"Marianne","family":"Frieri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,5,6]]},"reference":[{"key":"8487_CR1","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/0952-7915(90)90002-X","volume":"2","author":"J-P Kinet","year":"1990","unstructured":"Kinet J-P (1990) The high affinity receptor for IgE. Curr Opin Immunol 2:499\u2013505","journal-title":"Curr Opin Immunol"},{"key":"8487_CR2","doi-asserted-by":"crossref","first-page":"3281","DOI":"10.4049\/jimmunol.155.7.3281","volume":"155","author":"JC Cambier","year":"1995","unstructured":"Cambier JC (1995) Antigen and Fc receptor signaling: the awesome power of the immunoreceptor tyrosine based activation motif (ITAM). J Immunol 155:3281\u20135","journal-title":"J Immunol"},{"key":"8487_CR3","doi-asserted-by":"crossref","first-page":"9524","DOI":"10.1073\/pnas.89.20.9524","volume":"89","author":"H Fukamachi","year":"1992","unstructured":"Fukamachi H, Kawakami Y, Takei M et al (1992) Association of protein tyrosine kinase with phospholipase C-\u03b31 in bone marrow-derived mouse mast cells. Proc Natl Acad Sci U S A 89:9524\u20138","journal-title":"Proc Natl Acad Sci U S A"},{"key":"8487_CR4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1084\/jem.175.1.237","volume":"175","author":"SC Bischoff","year":"1992","unstructured":"Bischoff SC, Dahinden CA (1992) c-Kit ligand: a unique potentiator of mediator release by human lung mast cells. J Exp Med 175:237\u201344","journal-title":"J Exp Med"},{"issue":"4","key":"8487_CR5","first-page":"965","volume":"142","author":"SJ Galli","year":"1993","unstructured":"Galli SJ, Tsai M, Wershil BK (1993) The c-kit receptor, stem cell factor, and mast cells. What each is teaching us about the others. Am J Pathol 142(4):965\u201374","journal-title":"Am J Pathol"},{"key":"8487_CR6","first-page":"1","volume":"55","author":"SJ Galli","year":"1994","unstructured":"Galli SJ, Zsebo KM, Geissler EN (1994) The kit ligand, stem cell factor. Adv Immunol 55:1\u201396","journal-title":"Adv Immunol"},{"issue":"10","key":"8487_CR7","doi-asserted-by":"crossref","first-page":"3945","DOI":"10.4049\/jimmunol.156.10.3945","volume":"156","author":"NW Lukacs","year":"1996","unstructured":"Lukacs NW, Strieter RM, Lincoln PM et al (1996) Stem cell factor (c-kit ligand) influences eosinophil recruitment and histamine levels in allergic airway inflammation. J Immunol 156(10):3945\u201351","journal-title":"J Immunol"},{"issue":"2 Pt 2","key":"8487_CR8","doi-asserted-by":"crossref","first-page":"S527","DOI":"10.1016\/S0091-6749(00)90056-3","volume":"105","author":"CO Bingham III","year":"2000","unstructured":"Bingham CO III, Austen KF (2000) Mast-cell responses in the development of asthma. J Allergy Clin Immunol 105(2 Pt 2):S527\u201334","journal-title":"J Allergy Clin Immunol"},{"issue":"2","key":"8487_CR9","first-page":"321","volume":"144","author":"A Iemura","year":"1994","unstructured":"Iemura A, Tsai M, Ando A et al (1994) The c-kit ligand, stem cell factor, promotes mast cell survival by suppressing apoptosis. Am J Pathol 144(2):321\u20138","journal-title":"Am J Pathol"},{"issue":"1","key":"8487_CR10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000336374","volume":"159","author":"HP Horny","year":"2012","unstructured":"Horny HP, Sotlar K, Valent P (2012) Evaluation of mast cell activation syndromes: impact of pathology and immunohistology. Int Arch Allergy Immunol 159(1):1\u20135","journal-title":"Int Arch Allergy Immunol"},{"key":"8487_CR11","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1182\/blood.V79.4.958.bloodjournal794958","volume":"4","author":"CJ Meninger","year":"1992","unstructured":"Meninger CJ, Yano H, Rottapel R et al (1992) The c-kit receptor ligand functions as a mast cell chemoattractant. Blood 4:958\u201363","journal-title":"Blood"},{"issue":"11","key":"8487_CR12","doi-asserted-by":"crossref","first-page":"5428","DOI":"10.4049\/jimmunol.1103366","volume":"188","author":"T Ito","year":"2012","unstructured":"Ito T, Smr\u017e D, Jung MY et al (2012) Stem cell factor programs the mast cell activation phenotype. J Immunol 188(11):5428\u201337","journal-title":"J Immunol"},{"issue":"1","key":"8487_CR13","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/j.1600-065X.2008.00742.x","volume":"228","author":"AM Gilfillan","year":"2009","unstructured":"Gilfillan AM, Rivera J (2009) The tyrosine kinase network regulating mast cell activation. J Immunol Rev Immunol Rev 228(1):149\u201369","journal-title":"J Immunol Rev Immunol Rev"},{"key":"8487_CR14","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jaci.2010.08.035","volume":"126","author":"C Akin","year":"2010","unstructured":"Akin C, Valent P, Metcalfe DD (2010) Mast cell activation syndrome: proposed diagnostic criteria. J Allergy Clin Immunol 126:1099\u20131104","journal-title":"J Allergy Clin Immunol"},{"key":"8487_CR15","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaip.2014.03.007","volume":"2","author":"C Akin","year":"2014","unstructured":"Akin C (2014) Mast cell activation disorders. J Allergy Clin Immunol Pract 2:252\u201357","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"3","key":"8487_CR16","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1161\/01.HYP.0000158259.68614.40","volume":"45","author":"C Shibao","year":"2005","unstructured":"Shibao C, Arzubiaga C, 2nd Roberts LJ et al (2005) Hyperadrenergic postural tachycardia syndrome in mast cell activation disorders. Hypertension 45(3):385\u201390","journal-title":"Hypertension"},{"issue":"4","key":"8487_CR17","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jaapos.2013.04.002","volume":"17","author":"J Naysan","year":"2013","unstructured":"Naysan J, Kodsi S, Kristal L (2013) Solitary mastocytoma of the eyelid. J AAPOS 17(4):433\u2013434","journal-title":"J AAPOS"},{"issue":"5","key":"8487_CR18","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1097\/PAS.0b013e31824c0d92","volume":"36","author":"I Auquit-Auckbur","year":"2012","unstructured":"Auquit-Auckbur I, Lazar C, Deneuve S et al (2012) Malignant transformation of mastocytoma developed on skin mastocytosis into cutaneous mast cell sarcoma. Am J Surg Pathol 36(5):779\u201382","journal-title":"Am J Surg Pathol"},{"issue":"11","key":"8487_CR19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.prp.2012.06.010","volume":"208","author":"J Falleti","year":"2012","unstructured":"Falleti J, Borgia L, Lalinga AV et al (2012) Mast cell sarcoma of the scalp: the first sign of undisclosed systemic mastocytosis? Pathol Res Pract 208(11):683\u20136","journal-title":"Pathol Res Pract"},{"key":"8487_CR20","unstructured":"Frieri M (2009) Mastocytosis. Challenging cases in allergy and immunology Ed: Massoud Mahmoudi Chapter 14. pp201-212. Humana Press"},{"key":"8487_CR21","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1182\/blood-2006-06-028100","volume":"110","author":"C Akin","year":"2007","unstructured":"Akin C, Scott LM, Kocabas CN et al (2007) Demonstration of an aberrant mast-cell population with clonal markers in a subset of patients with \u201cidiopathic\u201d anaphylaxis. Blood 110:2331\u20133","journal-title":"Blood"},{"key":"8487_CR22","doi-asserted-by":"crossref","first-page":"S68a","DOI":"10.1016\/j.jaci.2007.12.273","volume":"121","author":"AP Koterba","year":"2008","unstructured":"Koterba AP, Akin C (2008) Differences in the clinical presentation of anaphylaxis in patients with indolent systemic mastocytosis (ISM) versus idiopathic anaphylaxis (IA). J Allergy Clin Immunol 121:S68a, abstract","journal-title":"J Allergy Clin Immunol"},{"key":"8487_CR23","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jaip.2014.02.012","volume":"2","author":"P Greenberger","year":"2014","unstructured":"Greenberger P, Lieberman P (2014) Idiopathic anaphylaxis. J Allergy Clin Immunol 2:243\u2013250, In Practice Issue #3","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"8487_CR24","first-page":"S483","volume":"115","author":"P Lieberman","year":"2005","unstructured":"Lieberman P et al (2005) An updated practice parameter EdsIdiopathic anaphylaxis. Diagnosis Manage Anaphylaxis 115(3):S483\u2013S523","journal-title":"Diagnosis Manage Anaphylaxis"},{"key":"8487_CR25","doi-asserted-by":"crossref","unstructured":"Valent P, Akin C, Arock M et al (2012) Definitions, criteria & global classification of MC disorders with special reference to MCAS: a consensus proposal. Int Arch Allergy Immunol 157(3):215\u201325","DOI":"10.1159\/000328760"},{"issue":"6","key":"8487_CR26","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/j.jaci.2010.02.019","volume":"125","author":"I Alvarez-Twose","year":"2010","unstructured":"Alvarez-Twose I, de Gonz\u00e1lez OD, S\u00e1nchez-Mu\u00f1oz L et al (2010) Clinical, biological, and molecular characteristics of clonal mast cell disorders presenting with systemic mast cell activation symptoms. J Allergy Clin Immunol 125(6):1269\u20131278","journal-title":"J Allergy Clin Immunol"},{"key":"8487_CR27","unstructured":"Frieri M (2009) Anaphylaxis. Chapter 68, pp721-730. In: Manual of Critical Care, Philadelphia, Pa. American College of Physicians"},{"key":"8487_CR28","doi-asserted-by":"crossref","unstructured":"Matito A, Alvarez-Twose I, Morgado JM et al (2014) Anaphylaxis as a clinical manifestation of clonal mast cell disorders. Curr Allergy Asthma Rep 14(8):450","DOI":"10.1007\/s11882-014-0450-8"},{"key":"8487_CR29","doi-asserted-by":"crossref","unstructured":"Hamilton MJ, Hornick JL, Akin C et al (2011) A newly recognized disorder with systemic clinical manifestations. J Allergy Clin Immunol 128(1):147\u2013152","DOI":"10.1016\/j.jaci.2011.04.037"},{"issue":"1","key":"8487_CR30","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2500\/108854100778249006","volume":"21","author":"DD Metcalfe","year":"2000","unstructured":"Metcalfe DD (2000) Differential diagnosis of the patient with unexplained flushing\/anaphylaxis. Allergy Asthma Proc 21(1):21\u201324","journal-title":"Allergy Asthma Proc"},{"issue":"5","key":"8487_CR31","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.revmed.2013.08.015","volume":"35","author":"E Lafont","year":"2014","unstructured":"Lafont E et al (2014) Causes and diffential diagnosis of flush. Rev Med Interne 35(5):303\u20139","journal-title":"Rev Med Interne"},{"issue":"5","key":"8487_CR32","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.clinthera.2013.04.001","volume":"35","author":"M Picard","year":"2013","unstructured":"Picard M, Giavina-Bianchi P, Mezzano V et al (2013) Expanding spectrum of mast cell activation disorders: monoclonal and idiopathic mast cell activation syndromes. Clin Ther 35(5):548\u201362","journal-title":"Clin Ther"},{"issue":"4","key":"8487_CR33","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1002\/ajh.23459","volume":"87","author":"A Pardanani","year":"2012","unstructured":"Pardanani A (2012) Systemic mastocytosis in adults. Update on diagnosis, risk stratification, and management. Am J Hematol 87(4):401\u201311","journal-title":"Am J Hematol"},{"key":"8487_CR34","doi-asserted-by":"crossref","first-page":"l26","DOI":"10.1016\/S0091-6749(05)80132-0","volume":"86","author":"M Frieri","year":"1990","unstructured":"Frieri M, Linn N, Schweitzer M, Angadi C et al (1990) Lymphadenopathic mastocytosis with eosinophilia and biclonal gammopathy. J Allergy Clin Immuno 86:l26\u2013132","journal-title":"J Allergy Clin Immuno"},{"issue":"2","key":"8487_CR35","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1053\/j.seminhematol.2012.01.007","volume":"49","author":"J Gotlib","year":"2012","unstructured":"Gotlib J, Akin C (2012) Mast cells and eosinophils in mastocytosis, chronic eosinophilic leukemia, and non-clonal disorders. Semin Hematol 49(2):128\u201337","journal-title":"Semin Hematol"},{"key":"8487_CR36","unstructured":"Bai Y, Bandara G, Ching Chan E (2012) Targeting the KIT activating switch control pocket: a novel mechanism to inhibit neoplastic mast cell proliferation and mast cell activation. Leukemia 27(2):278\u201385"},{"key":"8487_CR37","first-page":"229","volume":"3","author":"HJ Bax","year":"2012","unstructured":"Bax HJ, Keeble AH, Gould HJ (2012) Cytokinergic IgE action in mast cell activation. Frontiers Immunol Inflamm Vol 3:229","journal-title":"Frontiers Immunol Inflamm Vol"},{"key":"8487_CR38","doi-asserted-by":"crossref","unstructured":"Patel R, Celestin J, Frieri M (2012) An unusual case of mast cell activation syndrome. J Allergy Clin Immunol;, abs #475","DOI":"10.1016\/j.jaci.2011.12.414"},{"issue":"1","key":"8487_CR39","doi-asserted-by":"crossref","first-page":"113","DOI":"10.7205\/MILMED-D-11-00111","volume":"177","author":"LB Afrin","year":"2012","unstructured":"Afrin LB (2012) Mast cell activation syndrome masquerading as agranulocytosis. Mil Med 177(1):113\u20137","journal-title":"Mil Med"},{"issue":"3","key":"8487_CR40","first-page":"655","volume":"27","author":"SK Kritas","year":"2013","unstructured":"Kritas SK, Saggini A, Varvara G et al (2013) Mast cell involvement in rheumatoid arthritis. J Biol Regul Homeost Agents 27(3):655\u201360","journal-title":"J Biol Regul Homeost Agents"},{"key":"8487_CR41","first-page":"1","volume":"72","author":"M Frieri","year":"1994","unstructured":"Frieri M, Agarwal K, Datar A, Trotta P (1994) Increased interleukin-4 production in response to mast cell mediators and human type I collagen in patients with rheumatoid arthritis. Ann Allergy 72:1\u20138","journal-title":"Ann Allergy"},{"issue":"3","key":"8487_CR42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.prp.2011.12.005","volume":"208","author":"LB Afrin","year":"2012","unstructured":"Afrin LB (2012) Sclerosing mediastinitis and mast cell activation syndrome. Pathol Res Pract 208(3):181\u20135","journal-title":"Pathol Res Pract"},{"key":"8487_CR43","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/art.1780340510","volume":"34","author":"E Hawrylko","year":"1991","unstructured":"Hawrylko E, Spertus A, Mele C et al (1991) Increased interleukin-2 production in response to human type I collagen stimulation in patients with systemic sclerosis. Arthritis Rheum 34:580","journal-title":"Arthritis Rheum"},{"key":"8487_CR44","first-page":"385","volume":"69","author":"M Frieri","year":"1992","unstructured":"Frieri M (1992) Systemic sclerosis. The role of the mast cell and cytokines. Ann Allergy 69:385\u2013397","journal-title":"Ann Allergy"},{"key":"8487_CR45","unstructured":"Frieri M (1993) Systemic sclerosis and related antinuclear antibody serologies. Immunopath; 17:#5, IP 93\u20135, 1\u20139"},{"issue":"1","key":"8487_CR46","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s11882-012-0322-z","volume":"13","author":"M Frieri","year":"2013","unstructured":"Frieri M, Patel R, Celestin J (2013) Mast cell activation syndrome: a review. Curr Allergy Asthma Rep 13(1):27\u201332","journal-title":"Curr Allergy Asthma Rep"},{"issue":"#4","key":"8487_CR47","first-page":"175","volume":"26","author":"M Frieri","year":"2013","unstructured":"Frieri M, Quershi M (2013) Pediatric mastocytosis. Review of the literature. Ped Allergy Asthma Pulmonol 26(#4):175\u2013180","journal-title":"Ped Allergy Asthma Pulmonol"},{"issue":"1","key":"8487_CR48","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11882-012-0326-8","volume":"13","author":"JC Cardet","year":"2013","unstructured":"Cardet JC, Castells MC, Hamilton MJ (2013) Immunology & clinical manifestations of non-clonal MCAS. Curr Allergy Asthma Rep 13(1):10\u20138","journal-title":"Curr Allergy Asthma Rep"},{"key":"8487_CR49","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.jaip.2013.09.004","volume":"2","author":"S Jennings","year":"2014","unstructured":"Jennings S, Russell N, Jennings B et al (2014) The mastocytosis society survey on mast cell disorders: patient experiences and perception. J Allergy Clin Immunol Pract 2:70\u20136","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"8487_CR50","first-page":"384","volume":"108","author":"MC Bell","year":"2012","unstructured":"Bell MC, Jackson DJ (2012) Anaphylaxis prevention related to MCAS with omalizumab letters. Ann Allergy Asthma Immunol 108(5):384\u2013384","journal-title":"Ann Allergy Asthma Immunol"},{"key":"8487_CR51","first-page":"266","volume":"2","author":"K Sokol","year":"2014","unstructured":"Sokol K, Ghazi A, Kelly BC et al (2014) Omalizumab as a desensitizing agent and treatment in mastocytosis. Rev Case Report J Allergy Clin Immunol Prac 2:266\u2013758","journal-title":"Rev Case Report J Allergy Clin Immunol Prac"},{"issue":"1","key":"8487_CR52","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.anai.2014.05.001","volume":"113","author":"A Jagdis","year":"2014","unstructured":"Jagdis A, Vadas P (2014) Omalizumab effectively prevents recurrent refractory anaphylaxis in a patient with monoclonal mast cell activation syndrome. Annals Allergy, Asthma Immunol 113(1):115\u2013116","journal-title":"Annals Allergy, Asthma Immunol"},{"issue":"6","key":"8487_CR53","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1586\/1744666X.2014.906302","volume":"10","author":"A Petra","year":"2014","unstructured":"Petra A, Panagiotidou S, Stewart JM et al (2014) Spectrum of mast cell activation disorders. Expert Rev Clin Immunol 10(6):729\u201339","journal-title":"Expert Rev Clin Immunol"},{"issue":"2","key":"8487_CR54","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.iac.2014.01.003","volume":"34","author":"K Brockow","year":"2014","unstructured":"Brockow K (2014) Epidemiology, prognosis, risk factors in mastocytosis. Immunol Allergy Clin North Am 34(2):283\u2013295","journal-title":"Immunol Allergy Clin North Am"},{"issue":"5","key":"8487_CR55","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jaci.2013.11.030","volume":"133","author":"HK Yip","year":"2014","unstructured":"Yip HK, Kolesnikoff N, Yu C et al (2014) Mechanisms of vitamin D3 metabolite repression of IgE-dependent mast cell activation. J Allergy Clin Immunol 133(5):1356\u201364","journal-title":"J Allergy Clin Immunol"},{"key":"8487_CR56","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1016\/j.jaci.2013.11.030","volume":"133","author":"V Sabato","year":"2014","unstructured":"Sabato V, Van De Vijver E, Hagendorens M et al (2014) Mast cell activation. Familial hypertryptasemia with associated mast cell activation syndrome. J Allergy Clin Immunol 133:1356\u20131364","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8487_CR57","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1159\/000351807","volume":"227","author":"M Wiednig","year":"2013","unstructured":"Wiednig M, Beham-Schmid C, Kranzelbinder B et al (2013) Clonal mast cell proliferation in pruriginous skin in hypereosinophilic syndrome. Dermatology 227(1):67\u201371","journal-title":"Dermatology"},{"issue":"6","key":"8487_CR58","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1097\/PAS.0000000000000190","volume":"38","author":"LA Doyle","year":"2014","unstructured":"Doyle LA, Sepehr GJ, Hamilton MJ et al (2014) A clinicopathologic study of 24 cases of systemic mastocytosis involving the gastrointestinal tract and assessment of mucosal mast cell density in irritable bowel syndrome and asymptomatic patients. Am J Surg Pathol 38(6):832\u201343","journal-title":"Am J Surg Pathol"},{"key":"8487_CR59","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jaci.2014.05.001","volume":"134","author":"S-L Hwang","year":"2014","unstructured":"Hwang S-L, Lu Y, Li X (2014) ERK1\/2 antagonize AMPK-dependent regulation of Fc\u03b5RI-mediated mast cell activation and anaphylaxis. J Allergy Clin Immunol 134:714\u201321","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"8487_CR60","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12967-014-0213-2","volume":"12","author":"D Sch\u00e4fer","year":"2014","unstructured":"Sch\u00e4fer D, Dre\u00dfen P, Brettner S et al (2014) Prostaglandin D2-supplemented \u201cfunctional eicosanoid testing and typing\u201d assay with peripheral blood leukocytes as a new tool in the diagnosis of systemic mast cell activation disease: an explorative diagnostic study. J Transl Med 12(1):213","journal-title":"J Transl Med"},{"key":"8487_CR61","doi-asserted-by":"crossref","unstructured":"Sibilano R, Frossi B, Pucillo CE (2014) Mast cell activation: a complex interplay of positive and negative signaling pathways. Eur J Immunol; Jul 27","DOI":"10.1002\/eji.201444546"},{"issue":"2","key":"8487_CR62","doi-asserted-by":"crossref","first-page":"240","DOI":"10.4103\/0976-9668.136145","volume":"5","author":"NG Kounis","year":"2014","unstructured":"Kounis NG, Mazarakis A, Almpanis G et al (2014) The more allergens an atopic patient is exposed to, the easier and quicker anaphylactic shock and Kounis syndrome appear: clinical and therapeutic paradoxes. J Nat Sci Biol Med 5(2):240\u20134","journal-title":"J Nat Sci Biol Med"},{"issue":"4","key":"8487_CR63","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.anai.2013.09.017","volume":"112","author":"M Alevizos","year":"2014","unstructured":"Alevizos M, Karagkouni A, Panagiotidou S et al (2014) Stress triggers coronary mast cells leading to cardiac events. Ann Allergy Asthma Immunol 112(4):309\u201316","journal-title":"Ann Allergy Asthma Immunol"},{"issue":"1","key":"8487_CR64","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/2162-3619-2-28","volume":"2","author":"LB Afrin","year":"2013","unstructured":"Afrin LB (2013) Utility of hydroxyurea in mast cell activation syndrome. Exp Hematol Oncol 2(1):28","journal-title":"Exp Hematol Oncol"},{"key":"8487_CR65","doi-asserted-by":"crossref","unstructured":"Afrin LB (2014) Mast cell activation syndrome as a significant comorbidity in sickle cell disease. Am J Med Sci; Aug 28","DOI":"10.1097\/MAJ.0000000000000325"},{"issue":"9","key":"8487_CR66","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1111\/cea.12369","volume":"44","author":"T G\u00fclen","year":"2014","unstructured":"G\u00fclen T, H\u00e4gglund H, Sander B et al (2014) The presence of mast cell clonality in patients with unexplained anaphylaxis. Clin Exp Allergy 44(9):1179\u201387","journal-title":"Clin Exp Allergy"},{"issue":"3","key":"8487_CR67","doi-asserted-by":"crossref","first-page":"193","DOI":"10.4062\/biomolther.2014.038","volume":"22","author":"Y Lu","year":"2014","unstructured":"Lu Y, Li X, Park YN, Kwon O et al (2014) Britanin suppresses IgE\/Ag-induced mast cell activation by inhibiting the Syk pathway. Biomol Ther (Seoul) 22(3):193\u20139","journal-title":"Biomol Ther (Seoul)"},{"issue":"3","key":"8487_CR68","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.jaip.2014.03.007","volume":"2","author":"C Akin","year":"2014","unstructured":"Akin C (2014) Mast cell activation disorders. J Allergy Clin Immunol Pract 2(3):252\u20137","journal-title":"J Allergy Clin Immunol Pract"},{"issue":"5","key":"8487_CR69","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s00251-014-0768-3","volume":"66","author":"B Haenisch","year":"2014","unstructured":"Haenisch B, Fr\u00f6hlich H, Herms S et al (2014) Evidence for contribution of epigenetic mechanisms in the pathogenesis of systemic mast cell activation disease. Immunogenetics 66(5):287\u201397","journal-title":"Immunogenetics"}],"container-title":["Clinical Reviews in Allergy & Immunology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8487-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12016-015-8487-6\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8487-6","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12016-015-8487-6.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,10]],"date-time":"2023-08-10T03:01:02Z","timestamp":1691636462000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12016-015-8487-6"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,5,6]]},"references-count":69,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["8487"],"URL":"https:\/\/doi.org\/10.1007\/s12016-015-8487-6","relation":{},"ISSN":["1080-0549","1559-0267"],"issn-type":[{"value":"1080-0549","type":"print"},{"value":"1559-0267","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,5,6]]}}}